ARTICLE | Product Development
A COVID-19 first: Regeneron pushes mAb cocktail into clinic
June 12, 2020 2:26 AM UTC
Less than two weeks after the first COVID-19 mAbs entered human testing, Regeneron became the first company to bring a COVID-19 mAb cocktail into the clinic.
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced on Thursday the start of its clinical REGN-COV2 program. ...
BCIQ Company Profiles
BCIQ Target Profiles